Group items tagged

The UK Health Security Agency (UKHSA) has advised self-isolation for people diagnosed with monkeypox to reduce the risk of spreading the infection. Household members are at the highest risk of becoming infected from a case within their house. The new guidance advises people with monkeypox infection to take steps to try and limit transmission within the household. "Monkeypox infection mainly spreads between people through direct, skin-to-skin contact, including sexual contact. Infection can also be spread via contaminated objects such as linen and soft furnishings," said UKHSA. The guidance advises that, where possible, cases are encouraged to sleep and eat in a separate room and use a separate bathroom to their household if possible. Good hygiene measures, to follow at all times, have also been set out. It suggests, "Where the use of a separate room isn't possible, cases should avoid physical contact and keep at least three steps (one metre) away from all household members. It is particularly important that they avoid close contact with young children, pregnant women and immunosuppressed people as they may be at higher risk of serious illness."

Are you frank enough about talking sex? It is a bold topic for everyone. People who are open about this stuff are perceived as vulgar and a bad company that should be avoided. Now, it is well established that sexual intercourse or sex talk is the founding stone for having babies. How you can become aware about your as well as other partner sexual needs? Communication through talking is the link towards enlightenment. To become sexually aware aids in the personal hygiene and satisfaction of the married couple.

Urinary tract infection is very common condition ,specially effecting females.But it also occurs in males.It is more common in women of reproductive age group,specially in sexually active women.

In its first, the National Institute for Health and Care Excellence (NICE) has recommended the use of Pre Exposure Prophylaxis (PrEP) to treat people at the highest risk of catching HIV. The announcement comes along with a consultation on draft guideline by NICE on reducing sexually transmitted infections. NICE's recommendation is backed up by the government's HIV Action Plan to hit zero new transmissions of HIV by 2030. The pill prevents HIV by stopping the virus from crossing into the healthy cells and replicating. According to the UK PROUD study, PrEP reduced the risk of HIV infection by 86 per cent for men who have sex with men. However, people taking the pill must also get regular HIV testing and STI screening done every three months.

Ahead of World AIDS Day this Wednesday, the Royal Pharmaceutical Society has urged the government to widen access to pre-exposure prophylaxis (PrEP) by making it available through community pharmacies. It argues that such a move could drive down rates of HIV infection across Great Britain. Currently, the medicine - which offers almost total protection from HIV when taken as recommended prior to sex or injecting drugs - is available free of charge only through sexual health clinics. Calling on the government to engage with community pharmacies to improve public health, RPS president Claire Anderson said: "There is a clear opportunity to drive down rates of HIV infection by expanding provision of pre-exposure prophylaxis (PrEP) to community pharmacies and GP practices as part of the government's HIV Action Plan.

Most of the Race / Ethnicity Americans have been directly affected by HIV/AIDS as the epidemic's start. Many challenges add to the epidemic between different Races / Ethnicity, including lack of access to proper health care, poverty, a large amount of sexually transmitted infections, smaller sexual networks, lack of information about the HIV situation, and stigma. We should treat everyone equally and fight together to defect HIV/AIDS from its root. Visit Our Website: https://drpounders.com/ or Call Us at 214-520-8833

The market is broadly segmented into instruments, assays & kits, and services & software based on the basis of products & services. The assays & kits segment is expected to account for the largest share of the global POC molecular diagnostics market. This segment is also projected to register the highest CAGR during the forecast period. Based on the applications, the market is segmented into respiratory diseases, hospital-acquired infections (HAIs), sexually transmitted diseases (STDs), oncology, hepatitis, and other applications (meningococcal meningitis, malaria, Herpes Simplex Virus, Ebola, Zika virus).

The UK Health Security Agency (UKHSA) said last week (Aug 5) there were "early signs" that the monkeypox outbreak was plateauing across the country and that its expansion had slowed. "While the most recent data suggests the growth of the outbreak has slowed, we cannot be complacent," Dr Meera Chand, director of clinical and emerging infections at UKHSA, said. There were 2,859 confirmed and highly probable cases of monkeypox in the UK as of Aug. 4, with nearly 99 per cent of the cases among men, the country's health authority said in a statement. The recent analysis by the UKHSA showed that "monkeypox continues to be transmitted primarily in interconnected sexual networks of gay, bisexual, or other men who have sex with men", it added. British authorities in June were recommending gay and bisexual men at higher risk of exposure to monkeypox be offered a vaccine, as the outbreak of the viral disease had gathered pace, mostly in Europe.

In a significant leap forward in the fight against HIV, the Medicines and Healthcare products Regulatory Agency (MHRA) has given the green light to two groundbreaking formulations of cabotegravir. Apretude 30 mg film-coated tablets and Apretude 600 mg prolonged-release suspension for injection are now authorized for preventing sexually transmitted HIV-1 infection in adults and adolescents weighing at least 35kg at increased risk. This approval marks a pivotal moment in HIV (human immunodeficiency virus) prevention, offering an alternative to existing standard pre-exposure prophylaxis or PrEP treatments. HIV, a virus notorious for compromising the immune system, has long been a global health concern. Cabotegravir, a member of the integrase inhibitor group, works by blocking a key enzyme necessary for the replication of HIV-1, thereby reducing the virus's ability to spread.

Around 1.1 million people remain inhabiting with #HIV in the USA. Almost every one out of seven people is clueless about being infected with HIV. The intensity of the epidemic is comparatively low as compared to the overall population but is higher among some key affected populations. For More Information Visit Our Website https://drpounders.com/ or Call Us at 214-520-8833